Is Tempus AI, Inc. (TEM) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 14.2% / 30% | 8.1% / 30% | 3.4% / 30% | 0.99% / 5% | ✓ HALAL |
| DJIM | 14.2% / 33% | 8.1% / 33% | 3.4% / 33% | 0.99% / 5% | ✓ HALAL |
| MSCI | 58.3% / 33% | 33.2% / 33% | 14.1% / 33% | 0.99% / 5% | ✗ NOT HALAL |
| S&P | 14.2% / 33% | 8.1% / 33% | 3.4% / 33% | 0.99% / 5% | ✓ HALAL |
| FTSE | 58.3% / 33% | 33.2% / 33% | 14.1% / 50% | 0.99% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 62.7% | |
| Operating Margin | -16.7% | |
| Net Margin | -19.3% | |
| Return on Equity (ROE) | -89.5% | |
| Return on Assets (ROA) | -9.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$218M |
| Free Cash Flow | -$245M |
| Total Debt | $1.3B |
| Debt-to-Equity | 270.1 |
| Current Ratio | 3.1 |
| Total Assets | $2.3B |
Price & Trading
| Last Close | $45.53 |
| 50-Day MA | $55.45 |
| 200-Day MA | $68.79 |
| Avg Volume | 5.4M |
|
52-Week Range
$36.22
| |
About Tempus AI, Inc. (TEM)
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Purification Calculator
As a halal stock with 0.99% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Tempus AI, Inc. (TEM) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Tempus AI, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Tempus AI, Inc.'s debt ratio?
Tempus AI, Inc.'s debt ratio is 14.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 58.3%.
Does Tempus AI, Inc. require dividend purification?
Yes, Tempus AI, Inc. has an impermissible income ratio of 0.99%, which means 0.99% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Tempus AI, Inc.'s key financial metrics?
Tempus AI, Inc. has a market capitalization of $7.6B, and revenue of $1.3B. The company maintains a gross margin of 62.7% and a net margin of -19.3%. Return on equity stands at -89.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.